Achieving high rates of consent for genetic testing among African American smokers

Nicotine and Tobacco Research

Volumn 9, Issue 6, 2007, Pages 711-716

  Cox, Lisa Sanderson ^a   Bronars, Carrie A ^a   Thomas, Janet L ^a   Okuyemi, Kolawole S ^a   King, Gary ^b   Mayo, Matthew S ^a   Ahluwalia, Jasjit S ^c  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c University of Minnesota   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE GUM;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD SAMPLING; CIGARETTE SMOKING; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENETIC ANALYSIS; HEREDITY; HUMAN; INFORMED CONSENT; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; SMOKING CESSATION PROGRAM; SMOKING HABIT; TOBACCO DEPENDENCE;

ADULT; AFRICAN AMERICANS; ATTITUDE TO HEALTH; FEMALE; GENETIC SCREENING; HUMANS; INFORMED CONSENT; MALE; MIDDLE AGED; PATIENT PARTICIPATION; QUESTIONNAIRES; SMOKING; SMOKING CESSATION; UNITED STATES;

EID: 34250649253     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1080/14622200701365228     Document Type: Article

References (33)

1. Adams-Campbell, L. L., Ahaghotu, C., Gaskins, M., Dawkins, F. W., Smoot, D., Polk, O. D., Gooding, R. and DeWitty, R. L. (2004) Enrollment of African Americans onto clinical treatment trials: Study design barriers. Journal of Clinical Oncology, 22, pp. 730-734.
2. Ahluwalia, J. S., Harris, K. J., Catley, D., Okuyemi, K. S. and Mayo, M. S. (2002) Sustained-release bupropion for smoking cessation in African Americans: A randomized controlled trial. The Journal of the American Medical Association, 288, pp. 468-474.
3. Anney, R. J., Olsson, C. A., Lotfi-Miri, M., Patton, G. C. and Williamson, R. (2004) Nicotine dependence in a prospective population-based study of adolescents: The protective role of a functional tyrosine hydroxylase polymorphism. Pharmacogenetics, 14, pp. 73-81.
4. Batra, V., Patkar, A. A., Berrettini, W. H., Weinstein, S. P. and Leone, F. T. (2003) The genetic determinants of smoking. Chest, 123, pp. 1730-1739.
5. Caraballo, R. S., Giovino, G. A., Pechacek, T. F., Mowery, P. D., Richter, P. A., Strauss, W. J., Sharp, D. J., Eriksen, M. P., Pirkle, J. L. and Maurer, K. R. (1998) Racial and ethnic differences in serum cotinine levels of cigarette smokers: Third National Health and Nutrition Examination Survey, 1988-1991. The Journal of the American Medical Association, 280, pp. 135-139.
6. Centers for Disease Control and Prevention (2004) Cigarette smoking among adults - United States, 2002. Morbidity and Mortality Weekly Report, 53, pp. 427-431.
7. Chen, D. T., Rosenstein, D. L., Muthappan, P., Hilsenbeck, S. G., Miller, F. G., Emanuel, E. J. and Wendler, D. (2005) Research with stored biological samples: What do research participants want?. Archives of Internal Medicine, 165, pp. 652-655.
8. Comings, D. E., Ferry, L., Bradshaw-Robinson, S., Burchette, R., Chiu, C. and Muhleman, D. (1996) The dopamine D2 receptor (DRD2) gene: A genetic risk factor in smoking. Pharmacogenetics, 6, pp. 73-79.
9. Corbie-Smith, G., Thomas, S. B. and George, M. St D. (2002) Distrust, race, and research. Archives of Internal Medicine, 162, pp. 2458-2463.
10. Corbie-Smith, G., Thomas, S. B., Williams, M. V. and Moody-Ayers, S. (1999) Attitudes and beliefs of African Americans toward participation in medical research. Journal of General Internal Medicine, 14, pp. 537-546.
11. Cozier, Y. C., Palmer, J. R. and Rosenberg, L. (2004) Comparison of methods for collection of DNA samples by mail in the Black Women's Health Study. Annuals of Epidemiology, 14, pp. 117-122.
12. Dempsey, D., Tutka, P. 3rd., Jacob, P., Allen, F., Schoedel, K., Tyndale, R. F. and Benowitz, N. L. (2004) Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clinical Pharmacology and Therapeutics, 76, pp. 64-72.
13. Hu, S., Brody, C. L., Fisher, C., Gunzerath, L., Nelson, M. L., Sabol, S. Z., Sirota, L. A., Marcus, S. E., Greenberg, B. D., Murphy, D. L. and Hamer, D. H. (2000) Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior. Molecular Psychiatry, 5, pp. 181-188.
14. King, G., Polednak, A., Bendel, R. B., Vilsaint, M. C. and Nahata, S. B. (2004) Disparities in smoking cessation between African Americans and Whites: 1990-2000. American Journal of Public Health, 94, pp. 1965-1971.
15. Kozlowski, L. T., Vogler, G. P., Vandenbergh, D. J., Strasser, A. A., O'Connor, R. J. and Yost, B. A. (2002) Using a telephone survey to acquire genetic and behavioral data related to cigarette smoking in 'made-anonymous' and 'registry' samples. American Journal of Epidemiology, 156, pp. 68-77.
16. Lerman, C., Caporaso, N. E., Audrain, J., Main, D., Bowman, E. D., Lockshin, B., Boyd, N. R. and Shields, P. G. (1999) Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychology, 18, pp. 14-20.
17. Lerman, C., Caporaso, N. E., Audrain, J., Main, D., Boyd, N. R. and Shields, P. G. (2000) Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence. Molecular Psychiatry, 5, pp. 189-192.
18. Lerman, C., Shields, P. G., Wileyto, E. P., Audrain, J., Pinto, A., Hawk, L., Krishnan, S., Niaura, R. and Epstein, L. (2002) Pharmacogenetic investigation of smoking cessation treatment. Pharmacogenetics, 12, pp. 627-634.
19. Lerman, C., Wileyto, E. P., Patterson, F., Rukstalis, M., Audrain-McGovern, J., Restine, S., Shields, P. G., Kaufmann, V., Redden, D., Benowitz, N. and Berrettini, W. H. (2004) The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial. Pharmacogenomics Journal, 4, pp. 184-192.
20. Lueders, K. K., Hu, S., McHugh, L., Myakishev, M. V., Sirota, L. A. and Hamer, D. H. (2002) Genetic and functional analysis of single nucleotide polymorphisms in the beta2-neuronal nicotinic acetylcholine receptor gene (CHRNB2). Nicotine and Tobacco Research, 4, pp. 115-125.
21. Malaiyandi, V., Sellers, E. M. and Tyndale, R. F. (2005) Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence. Clinical Pharmacology and Therapeutics, 77, pp. 145-158.
22. McBride, C. M., Bepler, G., Lipkus, I. M., Lyna, P., Samsa, G., Albright, J., Datta, S. and Rimer, B. K. (2002) Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiology, Biomarkers, and Prevention, 11, pp. 521-528.
23. McKinney, E. F., Walton, R. T., Yudkin, P., Fuller, A., Haldar, N. A., Mant, D., Murphy, M., Welsh, K. I. and Marshall, S. E. (2000) Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers. Pharmacogenetics, 10, pp. 483-491.
24. McQuillan, G. M., Porter, K. S., Agelli, M. and Kington, R. (2003) Consent for genetic research in a general population: The NHANES experience. Genetic Medicine, 5, pp. 35-42.
25. Okuyemi, K. S., Ahluwalia, J. S., Ebersole-Robinson, M., Catley, D., Mayo, M. S. and Resnicow, K. (2003) Does menthol attenuate the effect of bupropion among African American smokers?. Addiction, 98, pp. 1387-1393.
26. Okuyemi, K. S., Cox, L. S., Nollen, N., Snow, P., Kaur, H., Choi, W. S., Nazir, N., Mayo, M. S. and Ahluwalia, J. S. (2007) A randomized clinical trial of African-American light smokers. American Journal of Health Promotion, 21, pp. 183-191.
27. Okuyemi, K. S., Scheibmeir, M., Butler, J. and Ahluwalia, J. S. (2003) Perceptions of smoking among African American light smokers. Substance Abuse, 24, pp. 191-193.
28. Radloff, L. S. (1977) The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, pp. 385-401.
29. Sellers, E. M., Tyndale, R. F. and Fernandes, L. C. (2003) Decreasing smoking behaviour and risk through CYP2A6 inhibition. Drug Discovery Today, 8, pp. 487-493.
30. Shields, P. G., Lerman, C., Audrain, J., Bowman, E. D., Main, D., Boyd, N. R. and Caporaso, N. E. (1998) Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians. Cancer Epidemiology, Biomarkers, and Prevention, 7, pp. 453-458.
31. True, W. R., Heath, A. C., Scherrer, J. F., Waterman, B., Goldberg, J., Lin, N., Eisen, S. A., Lyons, M. J. and Tsuang, M. T. (1997) Genetic and environmental contributions to smoking. Addiction, 92, pp. 1277-1287.
32. U.S. Department of Health and Human Services (1998) Tobacco use among U.S. racial/ethnic groups-African Americans, American Indian and Alaska Natives, Asian Americans and Pacific Islanders, and Hispanics: A report of the Surgeon General, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA
33. Woolf, S. H., Rothemich, S. F., Johnson, R. E. and Marsland, D. W. (2000) Selection bias from requiring patients to give consent to examine data for health services research. Archives of Family Medicine, 9, pp. 1111-1118.